Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: Psilocybin in Alcohol Use Disorder With Comorbid Depression [NA]

View source ↗

Summary

A completed clinical trial assessing psilocybin for alcohol use disorder with comorbid depression (sponsored by Centre Hospitalier Universitaire de Nîmes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Alcohol-Related Disorders, Depressive Disorder | NA | Status: COMPLETED